Brain+ A/S
CSE:BRAINP

Watchlist Manager

Brain+ A/S

CSE:BRAINP

Watchlist

Dividends

Discount Rate

Price: 0.102 DKK 6.25%

Market Cap: 17.5m DKK

Have any thoughts about
Brain+ A/S?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Estee Lauder Companies Inc NYSE:EL	Consumer products
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Church & Dwight Co Inc NYSE:CHD	Consumer products
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	American Express Co NYSE:AXP	Financial Services
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Target Corp NYSE:TGT	Retail
US	Walt Disney Co NYSE:DIS	Media
US	Mueller Industries Inc NYSE:MLI	Machinery
US	PayPal Holdings Inc NASDAQ:PYPL	Technology

Add Price Alert

Price Target:

Last Price: 0.102 DKK

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

BRAINP Alert

Brain+ A/S

0.102

+0.006 (+6.25%)

52 Week Range	0.0748 0.134
Price Target

We'll email you a reminder when the closing price reaches DKK.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Estee Lauder Companies Inc NYSE:EL	US
	Exxon Mobil Corp NYSE:XOM	US
	Church & Dwight Co Inc NYSE:CHD	US
	Pfizer Inc NYSE:PFE	US
	American Express Co NYSE:AXP	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Target Corp NYSE:TGT	US
	Walt Disney Co NYSE:DIS	US
	Mueller Industries Inc NYSE:MLI	US
	PayPal Holdings Inc NASDAQ:PYPL	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Brain+ A/S

What unique competitive advantages
does Brain+ A/S hold over its rivals?

What risks and challenges
does Brain+ A/S face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Brain+ A/S.

What unique competitive advantages
does Brain+ A/S hold over its rivals?

What risks and challenges
does Brain+ A/S face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Brain+ A/S.

Provide P/S
for Brain+ A/S.

Provide P/E
for Brain+ A/S.

Provide P/OCF
for Brain+ A/S.

Provide P/FCFE
for Brain+ A/S.

Provide P/B
for Brain+ A/S.

Provide EV/S
for Brain+ A/S.

Provide EV/GP
for Brain+ A/S.

Provide EV/EBITDA
for Brain+ A/S.

Provide EV/EBIT
for Brain+ A/S.

Provide EV/OCF
for Brain+ A/S.

Provide EV/FCFF
for Brain+ A/S.

Provide EV/IC
for Brain+ A/S.

Compare the intrinsic valuations
of Brain+ A/S and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Brain+ A/S against its competitors.

Analyze the profit margins
(gross, operating, and net) of Brain+ A/S compared to its peers.

Compare the P/E ratios
of Brain+ A/S against its peers.

Discuss the investment returns and shareholder value creation
comparing Brain+ A/S with its peers.

Analyze the financial leverage
of Brain+ A/S compared to its main competitors.

Show all profitability ratios
for Brain+ A/S.

Provide ROE
for Brain+ A/S.

Provide ROA
for Brain+ A/S.

Provide ROIC
for Brain+ A/S.

Provide ROCE
for Brain+ A/S.

Provide Gross Margin
for Brain+ A/S.

Provide Operating Margin
for Brain+ A/S.

Provide Net Margin
for Brain+ A/S.

Provide FCF Margin
for Brain+ A/S.

Show all solvency ratios
for Brain+ A/S.

Provide D/E Ratio
for Brain+ A/S.

Provide D/A Ratio
for Brain+ A/S.

Provide Interest Coverage Ratio
for Brain+ A/S.

Provide Altman Z-Score Ratio
for Brain+ A/S.

Provide Quick Ratio
for Brain+ A/S.

Provide Current Ratio
for Brain+ A/S.

Provide Cash Ratio
for Brain+ A/S.

What is the historical Revenue growth
over the last 5 years for Brain+ A/S?

What is the historical Net Income growth
over the last 5 years for Brain+ A/S?

What is the current Free Cash Flow
of Brain+ A/S?

Discuss the annual earnings per share (EPS)
trend over the past five years for Brain+ A/S.

BRAINP

Balance Sheet

Total Liabilities & Equity

Brain+ A/S
Total Liabilities & Equity

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

Adjust for Inflation

Brain+ A/S
Total Liabilities & Equity Peer Comparison

Comparables:

NNIT

MONSO

Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors

Company		Total Liabilities & Equity	CAGR 3Y	CAGR 5Y	CAGR 10Y
B	Brain+ A/S CSE:BRAINP	Total Liabilities & Equity kr36m	CAGR 3-Years 12%	CAGR 5-Years N/A	CAGR 10-Years N/A
N	NNIT A/S CSE:NNIT	Total Liabilities & Equity kr2B	CAGR 3-Years -9%	CAGR 5-Years -5%	CAGR 10-Years N/A
M	Monsenso A/S CSE:MONSO	Total Liabilities & Equity kr18.9m	CAGR 3-Years -13%	CAGR 5-Years 7%	CAGR 10-Years N/A

What is Brain+ A/S's Total Liabilities & Equity?

Total Liabilities & Equity
36m DKK

Based on the financial report for Dec 31, 2023, Brain+ A/S's Total Liabilities & Equity amounts to 36m DKK.

What is Brain+ A/S's Total Liabilities & Equity growth rate?

Total Liabilities & Equity CAGR 3Y
12%

Over the last year, the Total Liabilities & Equity growth was -21%. The average annual Total Liabilities & Equity growth rates for Brain+ A/S have been 12% over the past three years .

Brain+ A/S
CSE:BRAINP

Brain+ A/S
Total Liabilities & Equity

Brain+ A/S
Total Liabilities & Equity Peer Comparison

Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors

See Also

What is Brain+ A/S's Total Liabilities & Equity?

Total Liabilities & Equity
36m DKK

What is Brain+ A/S's Total Liabilities & Equity growth rate?

Total Liabilities & Equity CAGR 3Y
12%

Company

Help

Tools

Stocks

Brain+ A/S CSE:BRAINP

Brain+ A/S Total Liabilities & Equity

Brain+ A/S Total Liabilities & Equity Peer Comparison

Competitive Total Liabilities & Equity Analysis Latest Figures & CAGR of Competitors

See Also

What is Brain+ A/S's Total Liabilities & Equity? Total Liabilities & Equity 36m DKK

What is Brain+ A/S's Total Liabilities & Equity growth rate? Total Liabilities & Equity CAGR 3Y 12%

Company

Help

Tools

Stocks

Brain+ A/S
CSE:BRAINP

Brain+ A/S
Total Liabilities & Equity

Brain+ A/S
Total Liabilities & Equity Peer Comparison

Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors

What is Brain+ A/S's Total Liabilities & Equity?

Total Liabilities & Equity
36m DKK

What is Brain+ A/S's Total Liabilities & Equity growth rate?

Total Liabilities & Equity CAGR 3Y
12%